Literature DB >> 17684689

[Health care costs attributable to tobacco consumption on a national level in the Mexican Social Security Institute].

Luz Myriam Reynales-Shigematsu1, Rosibel de Los Angeles Rodríguez-Bolaños, Jorge Alberto Jiménez, Sergio Arturo Juárez-Márquez, Angélica Castro-Ríos, Mauricio Hernández-Avila.   

Abstract

OBJECTIVE: To estimate the cost of medical care for the major diseases attributable to tobacco consumption at the IMSS.
MATERIAL AND METHODS: A cost of illness (COI) analysis was carried out from the perspective of the health provider. A random sample of clinical files (n= 1,596) was reviewed to estimate the human resources and medical supplies's utilization according to the health care facilities. The smoking attributable fraction (SAF) by disease was used to derive costs attributable to tobacco consumption. The unitary cost was valuated in 2004 Mexican pesos (MP).
RESULTS: The estimated annual total cost of medical care was 7114 million MP for acute myocardial infarction (AMI); 3424 million MP for Cerebrovascular Disease, 1469 million MP for chronic obstructive pulmonary disease (COPD) and 102 million MP for lung cancer (LC). The annual total cost of medical care for IMSS was 12100 million MP. The total annual cost of medical care attributable to tobacco consumption corresponds to 7100 million MP, which is equivalent to 4.3% of the annual expenditures of the IMSS during 2004.
CONCLUSIONS: These results confirm the high medical costs associated with smoking. This information would be used to reinforce the tobacco control preventive actions at IMSS and support decision-makers in strengthening public policies to control tobacco use in Mexico.

Entities:  

Mesh:

Year:  2006        PMID: 17684689     DOI: 10.1590/s0036-36342006000700007

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  6 in total

1.  Promoting the effective translation of the framework convention on tobacco control: a case study of challenges and opportunities for strategic communications in Mexico.

Authors:  James F Thrasher; Luz Myriam Reynales-Shigematsu; Lourdes Baezconde-Garbanati; Victor Villalobos; Primavera Téllez-Girón; Edna Arillo-Santillán; Ana Dorantes-Alonso; Raydel Valdés-Salgado; Eduardo Lazcano-Ponce
Journal:  Eval Health Prof       Date:  2008-04-04       Impact factor: 2.651

2.  Assessment of the E-selectin rs5361 (561A>C) polymorphism and soluble protein concentration in acute coronary syndrome: association with circulating levels.

Authors:  Elena Sandoval-Pinto; Jorge Ramon Padilla-Gutiérrez; Emmanuel Valdes-Alvarado; Ilian Janet García-González; Angelica Valdez-Haro; Jose Francisco Muñoz-Valle; Hector Enrique Flores-Salinas; Fernando Rivas; Yeminia Valle
Journal:  Mediators Inflamm       Date:  2014-07-24       Impact factor: 4.711

3.  Medical care costs incurred by patients with smoking-related non-small cell lung cancer treated at the National Cancer Institute of Mexico.

Authors:  Oscar Arrieta; Roger Humberto Quintana-Carrillo; Gabriel Ahumada-Curiel; Jose Francisco Corona-Cruz; Elma Correa-Acevedo; Juan Zinser-Sierra; Dolores de la Mata-Moya; Alejandro Mohar-Betancourt; Vicente Morales-Oyarvide; Luz Myriam Reynales-Shigematsu
Journal:  Tob Induc Dis       Date:  2015-02-04       Impact factor: 2.600

4.  Global economic cost of smoking-attributable diseases.

Authors:  Mark Goodchild; Nigar Nargis; Edouard Tursan d'Espaignet
Journal:  Tob Control       Date:  2017-01-30       Impact factor: 7.552

Review 5.  Chronic Obstructive Pulmonary Disease in Latin America.

Authors:  Rogelio Perez-Padilla; Ana Maria B Menezes
Journal:  Ann Glob Health       Date:  2019-01-22       Impact factor: 2.462

6.  The distributional effects of tobacco tax increases across regions in Mexico: an extended cost-effectiveness analysis.

Authors:  Belen Saenz-de-Miera; Daphne C Wu; Beverly M Essue; Norman Maldonado; Prabhat Jha; Luz Myriam Reynales-Shigematsu
Journal:  Int J Equity Health       Date:  2022-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.